Obesity
Conditions
Interventions
Fucoxanthin capsule which contains 4mg, 1po bid for 28 days. Pre-and post intake, we evaluate physical findings, abdominal CT for visceral fat area, blood chemicals and urine analysis.
Sponsors
Kobe University. School of Medicine Dept. General Internal Medicine
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Healthy male adult volunteers
Exclusion criteria
Exclusion criteria: Patients who need medical treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physical findings including vital signs, blood serum chemicals including liver enzymes, creatinine, etc., and urine analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate visceral fat area by computed tomography | — |
Countries
Japan
Contacts
Public ContactMasayoshi Hashimoto
Kobe University. School of Medicine. Dept. Family & Community Medicine
Outcome results
None listed